Danaher the life sciences company rose 0.8% after Barclays upgraded the stock to overweight from equal weight, citing its diagnostics strength and bioprocessing momentum despite industry headwinds
Danaher the life sciences company rose 0.8% after Barclays upgraded the stock to overweight from equal weight, citing its diagnostics strength and bioprocessing momentum despite industry headwinds
At Cratos Asset Management, we aim to offer clients a wide range of financial products and services in order to enable them to achieve their personal financial aspirations.
© 2025 All rights reserved.